New AI method brings safer decisions to autonomous vehicles and healthcare
Peer-Reviewed Publication
Updates every hour. Last Updated: 11-Nov-2025 23:11 ET (12-Nov-2025 04:11 GMT/UTC)
Researchers have developed an innovative AI approach that embeds causal reasoning into offline reinforcement learning, enabling autonomous systems like driverless cars and medical support devices to make safer, more reliable decisions by accurately discerning true cause-and-effect relationships in historical data.
Researchers have developed a drone system that uses blockchain sharding to significantly enhance the speed, security, and real-time coordination of search and rescue missions.
Researchers have developed an innovative AI-driven system that automates and optimizes penetration testing, significantly reducing testing steps while expanding vulnerability assessments for large-scale networks.
Researchers at Shanghai Jiao Tong University have developed CHASER, a blockchain-based incentive system that transforms mobile crowdsensing by leveraging automated smart contracts and advanced encryption to deliver fair compensation, robust data security, and high efficiency, dramatically boosting user participation and reliability.
Researchers at Wuhan University have introduced Fair Adversarial Training (FairAT), a technique that enhances AI security and fairness by identifying and strengthening vulnerable data points, thereby reducing cyber-attack risks and mitigating ethical biases.
Researchers at Soochow University have unveiled DPEC, an advanced AI model that uses dual-view prompts and element correlation to significantly enhance spatial relation extraction from text, setting a new benchmark for technologies in autonomous driving, digital mapping, and smart personal assistants.
Proton pump inhibitors (PPIs) are frequently recommended for the management of gastroesophageal reflux disease (GERD) and peptic ulcers. This review article dwells upon various adverse effects that are associated with the extended use of PPIs and the mechanisms by which the PPIs lead to the progression of these complications, including Clostridium difficile infection (CDI) and pneumonia that develops due to impaired absorption caused by hypochlorhydria; cognitive impairment through decreased clearance of amyloid beta peptide and reduced synthesis of acetylcholine; osteoporosis that progresses due to reduced calcium absorption and disrupted bone remodeling through the effects on TRPM6/7 channels; Chronic kidney disease (CKD) caused by acute interstitial nephritis and vascular calcifications brought by hypomagnesemia; metabolic syndrome and type 2 Diabetes Mellitus. As such, clinicians must exercise carefulness when prescribing PPIs for extended periods. The most important aspect is the careful assessment of the indication prior to commencing the treatment, as well as reassessing the indication throughout its long-term administration.